Published on in Vol 8, No 1 (2022): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33550, first published .
Development and Evaluation of the Usefulness, Usability, and Feasibility of iNNOV Breast Cancer: Mixed Methods Study

Development and Evaluation of the Usefulness, Usability, and Feasibility of iNNOV Breast Cancer: Mixed Methods Study

Development and Evaluation of the Usefulness, Usability, and Feasibility of iNNOV Breast Cancer: Mixed Methods Study

Cristina Mendes-Santos   1, 2, 3, 4 , PhD ;   Francisco Nunes   5 , PhD ;   Elisabete Weiderpass   6 , MSc, MD, PhD ;   Rui Santana   3, 4 , PhD ;   Gerhard Andersson   7, 8, 9 , PhD

1 Department of Culture and Society, Linköping University, Linköping, Sweden

2 Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Porto, Portugal

3 Public Health Research Centre, NOVA National School of Public Health, Universidade Nova de Lisboa, Lisbon, Portugal

4 Comprehensive Health Research Center, Lisbon, Portugal

5 Fraunhofer Portugal AICOS, Porto, Portugal

6 International Agency for Research on Cancer, Lyon, France

7 Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden

8 Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

9 Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden

Corresponding Author: